720 related articles for article (PubMed ID: 18504683)
21. [Coagulation disorders during treatment with l-asparaginase preparations].
Dobaczewski G
Wiad Lek; 1998; 51 Suppl 4():227-32. PubMed ID: 10731973
[TBL] [Abstract][Full Text] [Related]
22. Thrombosis in children receiving L-asparaginase. Determining patients at risk.
Shapiro AD; Clarke SL; Christian JM; Odom LF; Hathaway WE
Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):400-5. PubMed ID: 8214362
[TBL] [Abstract][Full Text] [Related]
23. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T
Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511
[TBL] [Abstract][Full Text] [Related]
24. [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL].
Brodkiewicz A; Kamieńska E; Urasiński T; Peregud-Pogorzelski J
Acta Haematol Pol; 1995; 26(1):99-101. PubMed ID: 7747569
[TBL] [Abstract][Full Text] [Related]
25. [Neurologic complications during chemotherapy of children with acute lymphoid leukemia].
Kardos M; Grexa E; Kajtár P
Orv Hetil; 1992 May; 133(18):1111-5. PubMed ID: 1579351
[TBL] [Abstract][Full Text] [Related]
26. L-asparaginase related hyperglycemia.
Iyer RS; Rao SR; Pai S; Advani SH; Magrath IT
Indian J Cancer; 1993 Jun; 30(2):72-6. PubMed ID: 8225380
[TBL] [Abstract][Full Text] [Related]
27. [Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase].
Miyazawa Y; Irisawa H; Matsushima T; Mitsui T; Uchiumi H; Saitohi T; Handa H; Karasawa M; Murakami H; Tsukamoto N; Nojima Y
Rinsho Ketsueki; 2006 Jun; 47(6):531-5. PubMed ID: 16862982
[TBL] [Abstract][Full Text] [Related]
28. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
[TBL] [Abstract][Full Text] [Related]
29. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia.
Cetin M; Yetgin S; Kara A; Tuncer AM; Günay M; Gümrük F; Gürgey A
J Med; 1994; 25(3-4):219-29. PubMed ID: 7996065
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia.
Tomar S; Bakhshi S; Kabra SK; Arya LS
Indian Pediatr; 2003 Jul; 40(7):670-2. PubMed ID: 12881625
[No Abstract] [Full Text] [Related]
31. [Imaging methods in diagnosis of cerebrovascular complications with L-asparaginase therapy].
Fleischhack G; Solymosi L; Reiter A; Bender-Götze C; Eberl W; Bode U
Klin Padiatr; 1994; 206(4):334-41. PubMed ID: 7967435
[TBL] [Abstract][Full Text] [Related]
32. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
[TBL] [Abstract][Full Text] [Related]
33. Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase.
Bodmer M; Sulz M; Stadlmann S; Droll A; Terracciano L; Krähenbühl S
Digestion; 2006; 74(1):28-32. PubMed ID: 16988508
[TBL] [Abstract][Full Text] [Related]
34. [Transient diabetes mellitus with ketoacidosis in a child during the treatment of acute lymphoblastic leukemia with L-asparaginase].
Skomra S; Przybylska T
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):31-2. PubMed ID: 1409032
[TBL] [Abstract][Full Text] [Related]
35. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
Earl M
Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672
[TBL] [Abstract][Full Text] [Related]
36. Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.
Tsukamoto S; Takeuchi M; Kawajiri C; Tanaka S; Nagao Y; Sugita Y; Yamazaki A; Kawaguchi T; Muto T; Sakai S; Takeda Y; Ohwada C; Sakaida E; Shimizu N; Yokote K; Iseki T; Nakaseko C
Int J Hematol; 2012 Feb; 95(2):204-8. PubMed ID: 22160836
[TBL] [Abstract][Full Text] [Related]
37. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
[TBL] [Abstract][Full Text] [Related]
38. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
[TBL] [Abstract][Full Text] [Related]
39. Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy.
Salvador C; Meister B; Crazzolara R; Kropshofer G
Pediatr Blood Cancer; 2012 Oct; 59(4):771. PubMed ID: 22619026
[No Abstract] [Full Text] [Related]
40. L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report.
Misgar RA; Laway BA; Rahaman SH; Wani AI; Bashir MI; Bhat JR
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):439-41. PubMed ID: 25210761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
